Investigating the use of latent fingerprints for the detection of MDMA
Research type
Research Study
Full title
Investigating the use of latent fingerprints for the detection of MDMA (ecstasy)
IRAS ID
271705
Contact name
Kim Wolff
Contact email
Sponsor organisation
Intelligent Fingerprinting
Clinicaltrials.gov Identifier
N/A, N/A
Duration of Study in the UK
0 years, 8 months, 21 days
Research summary
The aim of this study is to investigate whether MDMA is detectable in the sweat deposited via latent fingerprints (LFP). This study will provide novel data to help understand whether the non-invasive method of sample collection using LFPs can be used for MDMA detection as well as other recreationally used drugs. In the literature, it has already been proven that drugs, e.g. nicotine, cocaine, MDMA, are excreted via sweat (Pacifici et al. 2001, Samyn et al. 2002, Barnes et al. 2009). Additional studies have shown drug detection in latent fingerprints (e.g. nicotine, Leggett et al (2007) is possible. However the presence of MDMA in LFPs still needs to be proven.
The use of LFPs is a non-invasive technique, which if this study is successful, can be used as a new and quick method of drug testing e.g.roadside testing. The first non-invasive LFPs sample will be taken on a test strip part of a point-of-care test. Test cartridges will be tested on site. The second latent fingerprint sample alongside the oral fluid sample will be stored at King's College London for analysis via mass spectrometry.
The site proposed for testing regularly treats MDMA users therefore making it a suitable location for testing. However, results will not be used in treatment plans but simply for research purposes.REC name
London - Fulham Research Ethics Committee
REC reference
20/LO/0075
Date of REC Opinion
4 Feb 2020
REC opinion
Favourable Opinion